Clinical Trials on Pulmonary Alveolar Proteinosis (PAP) in Japan
Total 6 results
-
Niigata University Medical & Dental HospitalCompletedPulmonary Alveolar Proteinosis, AutoimmuneJapan
-
Niigata University Medical & Dental HospitalCompletedPulmonary Alveolar Proteinosis, AutoimmuneJapan
-
Savara Inc.CompletedAutoimmune Pulmonary Alveolar ProteinosisUnited States, United Kingdom, Denmark, Switzerland, Australia, Portugal, Italy, Greece, Netherlands, Japan, Germany, France, Israel, Korea, Republic of, Russian Federation, Slovakia, Spain, Turkey
-
Savara Inc.Active, not recruitingAutoimmune Pulmonary Alveolar ProteinosisUnited States, Korea, Republic of, United Kingdom, Netherlands, Australia, Romania, Japan, Portugal, Canada, Greece, Spain, Italy, Poland, Belgium, France, Germany, Ireland, Turkey
-
Children's Hospital Medical Center, CincinnatiNational Center for Research Resources (NCRR); Rare Diseases Clinical Research...CompletedPulmonary Alveolar ProteinosisUnited States, Germany, Italy, Japan
-
ActelionActive, not recruitingPulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)United States, Japan, Taiwan, Turkey, Canada, China, Germany, Spain, Italy, Malaysia, Hungary, Russian Federation, Brazil, Australia, Bulgaria, Czechia, Mexico, Poland, South Africa